Literature DB >> 11907504

Sulfasalazine for alopecia areata.

Charles N Ellis1, Margaret F Brown, John J Voorhees.   

Abstract

Sulfasalazine is used as a therapy for various autoimmune conditions, including psoriasis; its effectiveness is presumed to be the result of its immunomodulatory effects. We have treated patients with severe alopecia areata with sulfasalazine as part of our dermatology practice and have noticed cosmetically acceptable regrowth in 23% of patients in whom a response could be determined. In view of its good safety profile, sulfasalazine may be considered for systemic treatment of severe alopecia areata.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907504     DOI: 10.1067/mjd.2002.119671

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Authors:  Robert C Miller; Daniel G Petereit; Jeff A Sloan; Heshan Liu; James A Martenson; James D Bearden; Ronald Sapiente; Grant R Seeger; Rex B Mowat; Ben Liem; Matthew J Iott; Charles L Loprinzi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-23       Impact factor: 7.038

2.  Alopecia areata: a new treatment plan.

Authors:  Adel Alsantali
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-07-22

3.  Androgenic alopecia is associated with less dietary soy, lower [corrected] blood vanadium and rs1160312 1 polymorphism in Taiwanese communities.

Authors:  Ching-Huang Lai; Nain-Feng Chu; Chi-Wen Chang; Shu-Li Wang; Hsin-Chou Yang; Chi-Ming Chu; Chu-Ting Chang; Ming-Huang Lin; Wu-Chien Chien; Sui-Lung Su; Yu-Ching Chou; Kang-Hua Chen; Wei-Ming Wang; Saou-Hsing Liou
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

4.  Effects of Acanthus ebracteatus Vahl. extract and verbascoside on human dermal papilla and murine macrophage.

Authors:  Vanuchawan Wisuitiprot; Kornkanok Ingkaninan; Panlop Chakkavittumrong; Wudtichai Wisuitiprot; Nitra Neungchamnong; Ruttanaporn Chantakul; Neti Waranuch
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.